Karen E. Bijwaard - Concepedia

Author

Karen E. Bijwaard

Armed Forces Institute of Pathology

Also Known As

K BIJWAARD, K Bijwaard, K. E. Bijwaard, KAREN E. BIJWAARD, Karen Bijwaard, Karen E Bijwaard, Karen E. Bijwaard

Publications

Citations

H-Index

Concepts

All Affiliations

Armed Forces Institute of Pathology United States Food and Drug Administration Center for Drug Evaluation and Research Center for Devices and Radiological Health National Institutes of Health

About

Karen E. Bijwaard is an author at Armed Forces Institute of Pathology specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.1K
2	Cell Biology	3	3	316
3	Engineering	2	2	206
4	Health Sciences	2	2	233
5	Diagnostic Sciences	1	1	95

Karen E. Bijwaard

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Initial Genetic Characterization of the 1918 “Spanish” Influenza Virus Jeffery K. Taubenberger, Ann Reid, Amy E. Krafft, Science	1997	709
Malignant Lymphoma of the Thyroid Gland Gregory A. Derringer, Lester D.�R. Thompson, R. Allen Frommelt, The American Journal of Surgical Pathology	2000	412
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring <i>BRAF V600E</i> Mutations Lauretta Odogwu, Luckson Mathieu, Gideon M. Blumenthal, The Oncologist	2018	212
Optimization of the isolation and amplification of RNA from formalin-fixed, paraffin-embedded tissue: The armed forces institute of pathology experience and literature review, * Amy E. Krafft, Beverly Duncan, Karen E. Bijwaard, Molecular Diagnosis Armed Forces InstituteEngineeringMedicineRna SplicingRna Biology	1997	164
U.S. Food and Drug Administration Approval: Crizotinib for Treatment of Advanced or Metastatic Non–Small Cell Lung Cancer That Is Anaplastic Lymphoma Kinase Positive Shakun Malik, V. Ellen Maher, Karen E. Bijwaard, Clinical Cancer Research Alk-positive NsclcPathologyPharmacotherapyPre-clinical PharmacologyOncology	2014	138
Nodular Lymphoid Hyperplasia of the Lung Susan L. Abbondanzo, Walter L. Rush, Karen E. Bijwaard, The American Journal of Surgical Pathology ImmunologyPathologyImmunotherapyHematologyMolecular Diagnostics	2000	137
CD4+CD25+ T Cells Prevent the Development of Organ-Specific Autoimmune Disease by Inhibiting the Differentiation of Autoreactive Effector T Cells Richard J. DiPaolo, Deborah D. Glass, Karen E. Bijwaard, The Journal of Immunology	2005	122
Quantitative Real-Time Reverse Transcription-PCR Assay for Cyclin D1 Expression: Utility in the Diagnosis of Mantle Cell Lymphoma Karen E. Bijwaard, Nadine S. Aguilera, Yury Monczak, Clinical Chemistry	2001	119
Immunoglobulin Heavy Chain Gene Analysis in Lymphomas Adam Bagg, Rita M. Braziel, Daniel A. Arber, Journal of Molecular Diagnostics Lymphoid NeoplasiaImmunogeneticsAutoimmune DiseaseImmunologyPathology	2002	100
Re-evaluation of “reactive lymphoid hyperplasia of the uvea” 1 1The opinions and assertions contained herein are the private views of the authors and are not to be construed as the views of the Department of the Air Force, Department of the Army, or the Department of Defense. Glenn C. Cockerham, Ahmed A. Hidayat, Karen E. Bijwaard, Ophthalmology Air ForceLymphoid NeoplasiaPrivate ViewsMedicinePhotocarcinogenesis	2000	95

Page 1